Eurofins Scientific acquired Beacon Discovery to significantly strengthen its expertise in drug discovery

▴ Eurofins Scientific acquired Beacon Discovery to significantly strengthen its expertise in drug discovery
Eurofins acquired Beacon Discovery for its innovative approach, years of experience in drug discovery and development

Eurofins Scientific, a world leader in bioanalytical tests announces the acquisition of Beacon Discovery, a contractual research (ORC) and drug discovery organization specializing in research on G protein-coupled receptors (GPCRs). Beacon Discovery integrates Eurofins Discovery, a leading CRO with the broadest portfolio of validated in vitro pharmacology, ADMET , and chemistry services for integrated drug discovery solutions. The transaction should be finalized in the coming weeks, subject to the satisfaction of customary closing conditions.

Eurofins acquired Beacon Discovery for its innovative approach, years of experience in drug discovery and development, as well as for its deep expertise in GPCR research, complemented by its unrivaled library of compounds. The acquisition of Beacon Discovery consolidates Eurofins' strategy, which consists of becoming the essential partner of the pharmaceutical industry, by bringing experience in drug discovery, knowledge and a proven track record in the discovery and development of new therapeutic agents. Beacon Discovery significantly enhances the capabilities and innovative methods of Eurofins Discovery to support and accelerate drug research and development, and to seize opportunities for

Dr Sunny Al-Shamma, CEO of Beacon Discovery, said: "Beacon Discovery is delighted to join Eurofins. Our arrival in the Eurofins Discovery organization strengthens our ability to continue our drug discovery efforts and provides integrated services in this area. , coupled with the additional capacities provided by Eurofins Discovery ".

Dr Gilles Martin, CEO of Eurofins, said: "Beacon Discovery strengthens expertise in GPCR targets, drug discovery and development experience in order to diversify our integrated service offering. This transaction once again demonstrates our commitment of Eurofins to provide the most comprehensive possible portfolio of laboratory services in the field of pharmacological discovery, which is currently experiencing a strong trend towards outsourcing.

Tags : #EurofinsScientific #LatestNewsonEurofinsScientific19thFeb #BeaconDiscovery #LatestPharmaNews19thFeb #LatestPharmaAcquisitionNews19thFeb

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024